Co-Diagnostics, Inc. announced that it held the ribbon cutting event for its new manufacturing facility in the City of South Salt Lake. The facility has been designed to manufacture the Co-Dx Pro instrument and test cups for the new platform, as well as the Company's patented Co-Primers chemistry that underpins the Company's PCR diagnostic tests. In attendance were South Salt Lake Mayor Cherie Wood and other leaders and dignitaries, including Kelvyn Cullimore, the President and CEO of Bio Utah, an independent trade organization serving the Utah life sciences community and focused on growing Utah into a global life sciences leader.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -1.57% | -14.97% | -6.02% |
06-14 | Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform | CI |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.02% | 39.1M | |
-34.27% | 14.75B | |
-54.93% | 2.22B | |
+15.49% | 1.82B | |
-14.07% | 1.43B | |
+21.99% | 1.23B | |
+1.25% | 784M | |
-35.50% | 741M | |
-36.65% | 723M | |
-28.15% | 602M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event